For: | O’Day R, Gillies MC, Ahlenstiel G. Ophthalmologic complications of antiviral therapy in hepatitis C treatment. World J Gastroenterol 2013; 19(45): 8227-8237 [PMID: 24363513 DOI: 10.3748/wjg.v19.i45.8227] |
---|---|
URL: | https://www.wjgnet.com/1007-9327/full/v19/i45/8227.htm |
Number | Citing Articles |
1 |
A. Rousseau, M. Labetoulle. Effets indésirables oculaires des traitements systémiques : une mise à jour. Journal Français d'Ophtalmologie 2015; 38(9): 876 doi: 10.1016/j.jfo.2015.05.004
|
2 |
Zubir S. Rentiya, Matthew Wells, Junun Bae, Kuan-Jen Chen, An-Ning Chao, Nicholas Turgeon, Syed M. Shah, Mostafa Hanout. Interferon-α-induced retinopathy in chronic hepatitis C treatment: summary, considerations, and recommendations. Graefe's Archive for Clinical and Experimental Ophthalmology 2019; 257(3): 447 doi: 10.1007/s00417-018-04209-7
|
3 |
Walid Sharif, Khayam Sheikh, Ian De Silva, Samer Elsherbiny. Nonarteritic anterior ischemic optic neuropathy associated with interferon and ribavirin in a patient with hepatitis C. American Journal of Ophthalmology Case Reports 2017; 5: 52 doi: 10.1016/j.ajoc.2016.12.004
|
4 |
Peng-Tai Tien, Chun-Ju Lin, Yi-Yu Tsai, Huan-Sheng Chen, De-Kuang Hwang, Chih-Hsin Muo, Jane-Ming Lin, Wen-Lu Chen. RELATIONSHIP BETWEEN UVEITIS, DIFFERENT TYPES OF VIRAL HEPATITIS, AND LIVER CIRRHOSIS. Retina 2016; 36(12): 2391 doi: 10.1097/IAE.0000000000001103
|
5 |
Faizah Ilyas, Harmanjit Singh, Navin Anand, Iqbal Ike K. Ahmed. Intraocular pressure rise in the course of peginterferon alpha-2a, ribavirin, and boceprevir therapy for hepatitis C. Canadian Journal of Ophthalmology 2015; 50(6): e112 doi: 10.1016/j.jcjo.2015.08.013
|